Biofrontera AG (ETR:B8FK)
Germany · Delayed Price · Currency is EUR 3.080
-0.040 (-1.28%)
Oct 26, 2026, 5:43 PM CET
Biofrontera AG Market Cap
Biofrontera AG has a market cap or net worth of €18.72 million as of October 26, 2026. It is the 36,482nd most valuable company in the world and the 485th biggest in Germany. Its market cap has increased by 15.36% in one year.
Market Cap
18.72M
Enterprise Value
13.24M
Revenue
15.97M
Global Rank
Country Rank
#485 Germany
PE Ratio
3.57
ChartMarket Cap Chart
Since October 31, 2006, Biofrontera AG's market cap has decreased from 38.05M to 18.72M, a decrease of -50.80%. That is a compound annual growth rate of -3.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 18.72M | 26.23% |
| Dec 30, 2025 | 14.83M | 13.49% |
| Dec 30, 2024 | 13.07M | -48.94% |
| Dec 29, 2023 | 25.59M | -73.70% |
| Dec 30, 2022 | 97.31M | 15.92% |
| Dec 30, 2021 | 83.94M | -42.36% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 62.48B |
| Siemens Healthineers AG | 46.76B |
| Bayer Aktiengesellschaft | 44.66B |
| Fresenius SE & Co. KGaA | 26.13B |
| FamiCord AG | 47.24M |
| Pentixapharm Holding AG | 42.01M |
| MeVis Medical Solutions AG | 37.13M |
| NanoRepro AG | 19.74M |